Dr. Luis J. Mejico, MD

Dr. Mejico practices at Infusion Center Neurology - HOPD in Syracuse, New York.

Dr. Mejico's NPI, 1366400152, was assigned on May 2, 2006. Dr. Mejico graduated from Catholic University of Cordoba Faculty of Medicine in 1994. Dr. Mejico holds New York license 218910.

Dr. Mejico's primary practice is Infusion Center Neurology - HOPD, at 90 Presidential Plz, Syracuse, NY 13202.

Dr. Mejico's primary practice is Infusion Center Neurology - HOPD in Syracuse, New York. Dr. Mejico is also affiliated with Upstate University Hospital. The medical group on file is Department of Neurology at SUNY Upstate Medical University. Dmand AI also links Dr. Mejico to 1 more group practice or clinic, named with a free account. Dr. Mejico's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mejico practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Mejico's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Mejico is licensed in New York.

CMS data shows 297 Medicare services from Dr. Mejico across 9 procedure codes in 2024, for 117 Medicare patients. Medicare paid $10,905 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 117 Medicare patients who saw Dr. Mejico in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mejico's median patient age at 49, with 70% women.

In 2024, Dr. Mejico wrote 452 Medicare Part D claims for 89 patients. 88% of them were for generic drugs. CMS names the drug for 357 of them, across 13 drugs with 11 or more claims each, at $49,914 in total drug cost. In 2023, CMS named 323 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Mejico for performance year 2024, reported as part of a group. Dr. Mejico accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 16 papers to Dr. Mejico, published from 2011 to 2023. 2015 was the busiest year, with 2. The most frequent topics are Magnetic Resonance Imaging, Migraine Disorders and Botulinum Toxins, Type A. Dr. Mejico has published most often in Cureus. Dr. Mejico's most frequent co-authors are Robert K. Shin, MD, Awss Zidan, MD and Emmanuel Oladele Akano, MD.

CMS Open Payments shows 1 general payment to Dr. Mejico from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. IRRAS USA, Inc. paid the most, $70.

Dr. Mejico graduated from Catholic University of Cordoba Faculty of Medicine in 1994.